Read More 2 minute read Funding News News Therapeutics Kenai Therapeutics Secures $82M in Series A Funding Key Highlights $82 million Series A funding co-led by prestigious investors to fuel Kenai’s innovative approach to neurodegenerative diseases.… byChris-Anne RoqueMarch 6, 2024